Mika Ala-Korpela

Author PubWeight™ 82.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011 13.25
2 Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 2012 4.08
3 Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011 3.18
4 High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 2009 2.49
5 Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 2010 2.17
6 Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans. Arterioscler Thromb Vasc Biol 2005 2.07
7 Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 2012 1.98
8 Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet 2012 1.97
9 Long-term leisure-time physical activity and serum metabolome. Circulation 2012 1.81
10 Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 2012 1.80
11 Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 2012 1.78
12 Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet 2012 1.60
13 Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care 2012 1.57
14 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 2008 1.51
15 Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies. J Am Coll Cardiol 2013 1.35
16 Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes 2008 1.20
17 Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci. Hum Mol Genet 2011 1.13
18 High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J 2012 1.09
19 Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study. Diabetologia 2015 1.07
20 Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. MAGMA 2006 1.04
21 A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem Biophys Res Commun 2008 1.04
22 Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men. Diabetes 2011 0.99
23 Low-grade, systemic inflammation in adolescents: association with early-life factors, gender, and lifestyle. Am J Epidemiol 2009 0.99
24 1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps. NMR Biomed 2007 0.98
25 A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol. PLoS Genet 2011 0.97
26 Gender-dependent associations of metabolite profiles and body fat distribution in a healthy population with central obesity: towards metabolomics diagnostics. OMICS 2012 0.97
27 Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med 2009 0.94
28 Monitoring of gliomas in vivo by diffusion MRI and (1)H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids. NMR Biomed 2009 0.92
29 Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men. Diabetes 2013 0.92
30 Three-dimensional cryoEM reconstruction of native LDL particles to 16Å resolution at physiological body temperature. PLoS One 2011 0.92
31 Reconsideration of hydrophobic lipid distributions in lipoprotein particles. Chem Phys Lipids 2008 0.90
32 Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis. Mol Biosyst 2010 0.90
33 Multi-omic signature of body weight change: results from a population-based cohort study. BMC Med 2015 0.89
34 Fetal growth, omega-3 (n-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The Cardiovascular Risk in Young Finns Study. Am J Clin Nutr 2012 0.89
35 Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist. Ann Med 2013 0.89
36 A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data. BMC Bioinformatics 2007 0.88
37 Effect of repeated dietary counseling on serum lipoproteins from infancy to adulthood. Pediatrics 2012 0.88
38 Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care 2013 0.88
39 A differential network approach to exploring differences between biological states: an application to prediabetes. PLoS One 2011 0.87
40 Genetic and environmental determinants of total and high-molecular weight adiponectin in families with low HDL-cholesterol and early onset coronary heart disease. Atherosclerosis 2009 0.87
41 Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up. Atherosclerosis 2012 0.86
42 Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). J Proteome Res 2012 0.86
43 Letter by Ala-Korpela et al regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women". Circulation 2009 0.85
44 Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH. Atherosclerosis 2009 0.85
45 Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Am J Epidemiol 2012 0.85
46 Identification of mobile cholesterol compounds in experimental gliomas by (1)H MRS in vivo: effects of ganciclovir-induced apoptosis on lipids. FEBS Lett 2006 0.84
47 Evidence of how rs7575840 influences apolipoprotein B-containing lipid particles. Arterioscler Thromb Vasc Biol 2011 0.84
48 Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps. J Lipid Res 2009 0.83
49 Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the FinnDiane Study). Cardiovasc Diabetol 2009 0.83
50 Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. Atherosclerosis 2012 0.81
51 Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up. Lipids Health Dis 2014 0.81
52 Genome metabolome integrated network analysis to uncover connections between genetic variants and complex traits: an application to obesity. J R Soc Interface 2014 0.81
53 1H NMR at 800 MHz facilitates detailed phospholipid follow-up during atherogenic modifications in low density lipoproteins. Biochem Biophys Res Commun 2007 0.80
54 HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles. Alcohol Clin Exp Res 2008 0.80
55 Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study). Metabolomics 2011 0.80
56 Lipoprotein subclass profiles in young adults born preterm at very low birth weight. Lipids Health Dis 2013 0.79
57 Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study. Eur J Prev Cardiol 2011 0.79
58 High serum adiponectin is associated with favorable lipoprotein subclass profile in 6.4-year follow-up. Eur J Endocrinol 2011 0.79
59 The interplay between lipoprotein phenotypes, adiponectin, and alcohol consumption. Ann Med 2011 0.77
60 Effects of sea buckthorn and bilberry on serum metabolites differ according to baseline metabolic profiles in overweight women: a randomized crossover trial. Am J Clin Nutr 2013 0.76
61 Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study. Ann Med 2012 0.76
62 Association of height and pubertal timing with lipoprotein subclass profile: exploring the role of genetic and environmental effects. Am J Hum Biol 2013 0.76
63 Clinical and epidemiological metabonomics. J Biomed Biotechnol 2011 0.75
64 Application of quantitative artificial neural network analysis to 2D NMR spectra of hydrocarbon mixtures. J Chem Inf Comput Sci 2002 0.75